Capital Change - Retail Entitlement Offer

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

NZX RELEASE

17 March 2025


Capital Change Notice for Retail Entitlement Offer

Ryman Healthcare Limited (Ryman) (NZX: RYM) provides the attached Capital Change
Notice pursuant to NZX Listing Rule 3.13.1. This notice relates to the issue of 91,661,409
new ordinary shares (New Shares) under the retail entitlement offer component (Retail
Entitlement Offer) of the accelerated non-renounceable entitlement offer (Entitlement
Offer), as announced on 24 February 2025 (Offer).

ENDS

Authorised by:

Morgan Powell
General Counsel

About Ryman:
Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49
retirement villages in New Zealand and Australia. Ryman villages are home to 15,300
residents, and the company employs 7,700 staff.

Contacts:
For investor relations information contact Hayden Strickett, Head of Investor Relations, on
+64 27 303 1132 or hayden.strickett@rymanhealthcare.com

For media information contact Camille Middleditch on +64 28 422 3472 or
camille.middleditch@rymanexternal.com


Currency:
Unless otherwise stated, all references to “$” are to the New Zealand dollar.

Not an offer of securities in the United States:
This announcement has been prepared for publication in New Zealand and may not be
released or distributed in the United States. This announcement does not constitute an
offer, invitation or recommendation to subscribe for or purchase any security or financial
product and neither this announcement nor anything attached to this announcement shall
form the basis of any contract or commitment. In particular, this announcement does not
constitute an offer to sell, or the solicitation of an offer to buy, securities in the United
States or any other jurisdiction in which such an offer would be illegal. Any securities
described in this announcement have not been, and will not be, registered under the U.S.
Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any
state or other jurisdiction of the United States and may not be offered or sold, directly or
indirectly, in the United States except in transactions exempt from, or not subject to, the
registration requirements of the U.S. Securities Act and the securities laws of any state or
other jurisdiction of the United States. The New Shares to be offered and sold in the Retail
Entitlement Offer may only be offered and sold to persons that are not in the United States
and are not acting for the account or benefit of a person in the United States, in each case
in “offshore transactions” (as defined in Rule 902(h) under the U.S. Securities Act) in
reliance on Regulation S under the U.S. Securities Act.

---

Capital Change Notice




Section 1: Issuer information
Name of issuer Ryman Healthcare Limited
NZX ticker code RYM
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZRYME0001S4
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 91,661,409 ordinary shares issued
under the retail component of the
underwritten accelerated non-
renounceable entitlement offer
announced on 24 February 2025
(Retail Entitlement Offer).
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $3.05
Nature of the payment (for example, cash or other
consideration)
Cash
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number
of Financial Products of the Class, excluding any
Treasury Stock, in existence)
9.920%
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for example
the Conversion price and Conversion date and the
ranking of the Financial Product in relation to other
Classes of Financial Product) or the Option (for
example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific
authority for issue/acquisition/redemption/ (the reason
for change must be identified here)
Issue of ordinary shares under the
Retail Entitlement Offer announced on
24 February 2025
Total number of Financial Products of the Class after
the issue/acquisition/redemption/Conversion (excluding
Treasury Stock) and the total number of Financial
Products of the Class held as Treasury Stock after the
issue/acquisition/redemption.
1,015,712,784 ordinary shares.
No ordinary shares are held as
Treasury Stock.
In the case of an acquisition of shares, whether those
shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule pursuant
to which the issue, acquisition, or redemption is made
Board resolution dated 23 February
2025.
The accelerated entitlement offer is
made pursuant to NZX Listing Rules
4.3.1(a) and 4.4.

Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
Issue of ordinary shares which rank
equally with all other fully paid
ordinary shares in Ryman Healthcare
Limited.
Date of issue/acquisition/redemption 17/03/2025
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Morgan Powell, General Counsel
Contact person for this announcement Morgan Powell, General Counsel
Contact phone number +64 (0)21 246 6361
Contact email address morgan.powell@rymanhealthcare.com
Date of release through MAP

17/03/2025